Pulmotect: Funding, Investors & Team (Oct 2026)
Pulmotect has created PUL-042, a treatment that can be inhaled which is designed to enhance the body's natural immune system, offering specific protection to the lungs against a wide range of pathogens, such as bacteria, fungi, and viruses.
Pulmotect has raised $300k across 1 funding round on record, the most recent an undisclosed round of $300k announced in Jun 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Pulmotect Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Pulmotect Funding Rounds
Pulmotect Founders and Leadership Team
Contact details for the Pulmotect team: 1 of 1 has an email address on file.
Start 14-day free trial →Pulmotect Funding Compared to Other Biotechnology Startups
Pulmotect's latest round of $300k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Pulmotect in Biotechnology and Houston
Companies Similar to Pulmotect
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Pulmotect Funding FAQs
What does Pulmotect do?
Pulmotect has created PUL-042, a treatment that can be inhaled which is designed to enhance the body's natural immune system, offering specific protection to the lungs against a wide range of pathogens, such as bacteria, fungi, and viruses.
How much funding has Pulmotect raised?
Pulmotect has raised $300k across 1 round on record. The most recent is an undisclosed round of $300k announced in Jun 2023.
When did Pulmotect last raise funding?
Pulmotect's most recent funding round on record is an undisclosed round of $300k, announced in Jun 2023.
Who founded Pulmotect?
FundedIQ lists Brenton Scott (Founder) at Pulmotect.
Where is Pulmotect headquartered?
Pulmotect is based in Houston, Texas, United States.
How many employees does Pulmotect have?
Pulmotect is in the 1-10 employee band.
How does Pulmotect's funding compare to other Biotechnology startups?
Pulmotect's latest round of $300k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Pulmotect Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Pulmotect is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.